IA
MYGN icon

IFP Advisors’s Myriad Genetics MYGN Stock Holding History

IFP Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56K Buy
623
+56
+10% +$254 ﹤0.01% 3974
2026
Q1 		$2.55K Sell
567
-812
-59% -$4.23K ﹤0.01% 3863
2025
Q4 		$8.48K Buy
1,379
+552
+67% +$4K ﹤0.01% 3151
2025
Q3 		$5.98K Buy
827
+243
+42% +$1.44K ﹤0.01% 3146
2025
Q2 		$3.1K Buy
584
+420
+256% +$2.48K ﹤0.01% 3679
2025
Q1 		$1.46K Buy
164
+153
+1,391% +$1.84K ﹤0.01% 3244
2024
Q4 		$151 Buy
+11
New +$203 ﹤0.01% 3867
2020
Q1 		– Sell
-15
Closed -$317 – 2908
2019
Q4 		$0 Buy
+15
New +$413 ﹤0.01% 3019
2019
Q1 		– Sell
-225
Closed -$6K – 3029
2018
Q4 		$6K Sell
225
-1,869
-89% -$67.2K ﹤0.01% 2763
2018
Q3 		$96K Buy
2,094
+135
+7% +$6K ﹤0.01% 1494
2018
Q2 		$73K Buy
1,959
+725
+59% +$24.5K ﹤0.01% 1685
2018
Q1 		$42K Hold
1,234
– – ﹤0.01% 1920
2017
Q4 		$42K Buy
1,234
+685
+125% +$23.1K ﹤0.01% 1941
2017
Q3 		$20K Buy
549
+350
+176% +$9.98K ﹤0.01% 2586
2017
Q2 		$5K Sell
199
-41
-17% -$870 ﹤0.01% 3414
2017
Q1 		$5K Hold
240
– – ﹤0.01% 3308
2016
Q4 		$4K Sell
240
-630
-72% -$11.4K ﹤0.01% 3409
2016
Q3 		$18K Hold
870
– – ﹤0.01% 2469
2016
Q2 		$27K Buy
+870
New +$30.2K ﹤0.01% 2155
2016
Q1 		– Sell
-800
Closed -$35K – 3025
2015
Q4 		$35K Buy
+800
New +$33.8K ﹤0.01% 1821

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IFP Advisors's MYGN Position: Q2 2026 in Review

IFP Advisors increased its Myriad Genetics (MYGN) stake by 9.9% in Q2 2026, buying an estimated $254 and bringing the position to 623 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #3974.

IFP Advisors first reported a position in MYGN in Q4 2015 and has held it in 20 quarters since. The position peaked at $96K in Q3 2018. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • IFP Advisors held 623 shares of Myriad Genetics worth $3.56K as of Q2 2026.
  • IFP Advisors bought 56 Myriad Genetics shares in Q2 2026, an estimated $254.
  • Myriad Genetics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3974 holding.
  • IFP Advisors first reported a position in Myriad Genetics in Q4 2015 and has held it in 20 quarters since.
  • IFP Advisors's Myriad Genetics position peaked at $96K in Q3 2018.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.